JYNT Stock Analysis: Buy, Sell, or Hold?
JYNT - The Joint Corp.
$9.78
0.22 (2.30%)
β²
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When JYNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π‘ BUY OPPORTUNITY: JYNT shows positive signals but monitor for confirmation. Market pricing in 4.9% growth. Moderate conviction.
π‘ BUY OPPORTUNITY: JYNT shows positive signals but monitor for confirmation. Market pricing in 4.9% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.57
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.94
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: JYNT is currently trading at $9.78, which is considered slightly high relative to its 30-day fair value range of $8.87 to $10.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 35.0) compared to its historical average (30.3). At these levels, the market is pricing in 4.9% annual earnings growth.
Technical Outlook: Technically, JYNT is showing sideways momentum. Immediate support is located at $9.37, while resistance sits at $10.67.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.67 (+11.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, JYNT is showing sideways momentum. Immediate support is located at $9.37, while resistance sits at $10.67.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.67 (+11.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$8.87 -
$10.00
Company Quality Score
54/100
(HOLD)
Options IV Signal
25th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
72.7%
All Signals
- BULLISH: Options cheap (IV 25th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($10.67)
- BULLISH: Expecting earnings turnaround to 4.9% growth with 5.7% revenue growth
Fair Price Analysis
30-Day Fair Range
$8.87 -
$10.00
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
Β±$0.91
(9.3%)
Support & Resistance Levels
Support Level
$9.37
Resistance Level
$10.67
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
34.98
Wall Street Target
$10.67
(+11.6%)
Revenue Growth (YoY)
5.7%
Earnings Growth (YoY)
-11.5%
Profit Margin
-1.5%
Valuation Premium vs History
+4.9% premium
PE vs Historical
35.0 vs 30.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.9%
(market-implied from PE analysis)
1-Year Target
$10.03
(+5%)
2-Year Target
$10.52
(+10%)
3-Year Target
$11.04
(+15%)
3-Yr Target (if PE normalizes)
(PE: 35β30)
PE COMPRESSION
$9.56
(0%)
Earnings growth offset by PE compression
Last updated: January 31, 2026 11:39 AM ET
Data refreshes hourly during market hours. Next update: 12:39 PM
Data refreshes hourly during market hours. Next update: 12:39 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JYNT showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Christopher M Grandpre
BUY
10000 shares
2025-08-20
Christopher M Grandpre
BUY
10000 shares
2025-08-18
Christopher M Grandpre
BUY
14388 shares
2025-08-15
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$489 | 63 BUY |
|
THC
Tenet Healthcare Corpora⦠|
STRONG BUY
22 analysts |
$238 | 54 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$140 | 54 HOLD |
|
CMPS
Compass PathwaysΒ Plc |
STRONG BUY
11 analysts |
$17 | 52 HOLD |
|
CON
Concentra Group Holdings⦠|
STRONG BUY
8 analysts |
$28 | 62 BUY |
Advanced JYNT Option Strategies
Professional options setups generated by AI based on today's JYNT price and gamma walls.